Organised by Informa Markets in India, the 18th edition of CPHI & PMEC India 2025, South Asia’s premier pharmaceutical exhibition, will take place from November 25–27, 2025, at the India Expo Mart, Greater Noida, Delhi NCR. Known as the Heart of Pharma, the event will host over 2,000 exhibitors and 50,000+ professionals from 120+ countries, offering an unparalleled platform for business networking, technology exchange, and industry insights. Covering the entire pharmaceutical supply chain—from APIs, formulations, excipients, and fine chemicals to packaging, machinery, lab equipment, cleanroom technology, and contract services—the event will once again position India as a global hub for pharma innovation and manufacturing excellence.
Yogesh Mudras, Managing Director of Informa Markets in India, said, “The Indian pharmaceutical sector has evolved into a world-class ecosystem known for affordable generics, innovative R&D, and global healthcare contributions. With the government increasing its 2025–26 budget allocation for the Department of Pharmaceuticals by nearly 29% to ₹5,268 crore, there is renewed momentum in research, infrastructure, and capacity building. CPHI & PMEC India 2025 will serve as the ideal platform to accelerate collaboration, strengthen industry linkages, and build partnerships that define the future of Indian pharma.”
India’s pharmaceutical market is on an impressive growth trajectory—expected to reach USD 130 billion by 2030 and USD 450 billion by 2047. Reflecting this momentum, the 2025 edition will focus on core themes such as API self-reliance, sustainability, digitalization, and export expansion. It will spotlight innovations in ESG compliance, green manufacturing, and Pharma 4.0 technologies, showcasing India’s growing strength in sustainable and high-value pharmaceutical production.
The event will feature strong international participation from China, Italy, Germany, Switzerland, South Korea, and other major markets, encouraging global partnerships and trade synergies. Attendees can look forward to flagship sessions including the Pharma Leaders Roundtable, Women in Pharma Roundtable, CPHI Pharma Awards, and Pharma Connect Congress, designed to foster dialogue on leadership, diversity, and policy innovation.
A comprehensive knowledge exchange programme will complement the exhibition, offering conferences and panel discussions on key industry topics. Sessions will explore business resilience amid global shifts, innovation-led manufacturing for affordable medicines, and enhancing patient centricity beyond compliance. Expert panels will also discuss sustainability roadmaps, green packaging solutions, and low-carbon logistics, reflecting the industry’s commitment to responsible and future-ready growth.
Prominent exhibitors at CPHI & PMEC India 2025 will include Dr Reddy’s Laboratories, Hetero Labs, Oceanic Pharmachem, Akums Drugs & Pharmaceuticals, Morepen Laboratories, MSN Laboratories, Capsugel Healthcare, Biocon, and Jubilant Ingrevia. On the machinery side, leading companies such as ACG Pam Pharma Technologies, Cadmach Machinery, Ace Technologies & Packaging Systems, Parle Global Technologies, Klenzaids Contamination Controls, Gansons, Elmach Packages, Shimadzu India, and Snowbell Machines will showcase state-of-the-art solutions.
Supported by key industry bodies including Pharmexcil, IPEC India, BDMAI, OPPI, FOPE, and IPA, along with participation from policymakers and regulators, the event underscores its position as a trusted forum for policy advocacy, sustainable business practices, and collaborative growth. With its expansive global reach, strong innovation focus, and commitment to sustainability, CPHI & PMEC India 2025 continues to reinforce India’s position as the pharmacy of the world, driving the next phase of evolution for the global pharmaceutical ecosystem.
